IN2014MN01796A - - Google Patents

Download PDF

Info

Publication number
IN2014MN01796A
IN2014MN01796A IN1796MUN2014A IN2014MN01796A IN 2014MN01796 A IN2014MN01796 A IN 2014MN01796A IN 1796MUN2014 A IN1796MUN2014 A IN 1796MUN2014A IN 2014MN01796 A IN2014MN01796 A IN 2014MN01796A
Authority
IN
India
Prior art keywords
changes
glucose values
calculation
hatr
cbg
Prior art date
Application number
Other languages
English (en)
Inventor
Natalja Eikje
Original Assignee
Natalja Eikje
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Natalja Eikje filed Critical Natalja Eikje
Publication of IN2014MN01796A publication Critical patent/IN2014MN01796A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
    • A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
    • A61B5/1455—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue using optical sensors, e.g. spectral photometrical oximeters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/48—Other medical applications
    • A61B5/4866—Evaluating metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
    • A61B5/7235—Details of waveform analysis
    • A61B5/7253—Details of waveform analysis characterised by using transforms
    • A61B5/7257—Details of waveform analysis characterised by using transforms using Fourier transforms
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/30—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
    • A61B5/7271—Specific aspects of physiological measurement analysis
    • A61B5/7275—Determining trends in physiological measurement data; Predicting development of a medical condition based on physiological measurements, e.g. determining a risk factor

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biophysics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Optics & Photonics (AREA)
  • Databases & Information Systems (AREA)
  • Primary Health Care (AREA)
  • Epidemiology (AREA)
  • Data Mining & Analysis (AREA)
  • Emergency Medicine (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Obesity (AREA)
  • Psychiatry (AREA)
  • Artificial Intelligence (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Physiology (AREA)
  • Mathematical Physics (AREA)
  • Signal Processing (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Materials By Optical Means (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
IN1796MUN2014 2012-02-21 2013-02-21 IN2014MN01796A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261596250P 2012-02-21 2012-02-21
PCT/EE2013/000002 WO2013135249A2 (fr) 2012-02-21 2013-02-21 Formule et procédé pour surveiller une réponse métabolique individuelle et pour générer une métrique médicale prédictive

Publications (1)

Publication Number Publication Date
IN2014MN01796A true IN2014MN01796A (fr) 2015-07-03

Family

ID=49161899

Family Applications (1)

Application Number Title Priority Date Filing Date
IN1796MUN2014 IN2014MN01796A (fr) 2012-02-21 2013-02-21

Country Status (9)

Country Link
US (1) US10925521B2 (fr)
EP (1) EP2816953A2 (fr)
JP (2) JP2015510423A (fr)
KR (1) KR102079408B1 (fr)
CA (1) CA2902003C (fr)
IN (1) IN2014MN01796A (fr)
MY (1) MY199024A (fr)
SG (1) SG11201404625YA (fr)
WO (1) WO2013135249A2 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102655736B1 (ko) 2016-07-19 2024-04-05 삼성전자주식회사 이종 스펙트럼 기반 혈당 추정 장치 및 방법
KR102408951B1 (ko) 2017-09-18 2022-06-13 삼성전자주식회사 글루코스 노출량 추정 장치 및 방법과, 글루코스 노출량 추정 모델 생성 장치 및 방법
ES2774983B2 (es) 2019-01-22 2021-06-10 Univ Sevilla Dispositivo portable y metodo para la estimacion no invasiva del nivel de glucosa en sangre

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3093871B2 (ja) * 1991-05-22 2000-10-03 三井金属鉱業株式会社 光学的血糖値非破壊測定装置
US6240306B1 (en) * 1995-08-09 2001-05-29 Rio Grande Medical Technologies, Inc. Method and apparatus for non-invasive blood analyte measurement with fluid compartment equilibration
JPH11244266A (ja) * 1998-02-27 1999-09-14 Matsushita Electric Works Ltd 生体表層組織の分析方法及び生体表層組織の分析装置
US7027848B2 (en) 2002-04-04 2006-04-11 Inlight Solutions, Inc. Apparatus and method for non-invasive spectroscopic measurement of analytes in tissue using a matched reference analyte
JP2005147896A (ja) * 2003-11-17 2005-06-09 Kagawa Univ 混合溶液成分の濃度測定方法および濃度測定装置
JP2007117221A (ja) * 2005-10-25 2007-05-17 Hirato Koji Ｆｔｉｒを用いた非侵襲血液検査「光人間ドックシステム」
EP2460470A4 (fr) * 2009-07-28 2015-04-22 Panasonic Healthcare Co Ltd Dispositif d'estimation de taux de glycémie
WO2013129519A1 (fr) * 2012-02-29 2013-09-06 国立大学法人香川大学 Dispositif de mesure de caractéristiques spectrales et procédé de mesure de caractéristiques spectrales

Also Published As

Publication number Publication date
KR102079408B1 (ko) 2020-04-08
WO2013135249A3 (fr) 2014-03-06
MY199024A (en) 2023-10-10
EP2816953A2 (fr) 2014-12-31
SG11201404625YA (en) 2014-10-30
JP2019122775A (ja) 2019-07-25
US10925521B2 (en) 2021-02-23
US20200245909A1 (en) 2020-08-06
JP2015510423A (ja) 2015-04-09
CA2902003A1 (fr) 2013-09-19
WO2013135249A2 (fr) 2013-09-19
CA2902003C (fr) 2024-04-30
KR20140134298A (ko) 2014-11-21

Similar Documents

Publication Publication Date Title
WO2011008520A3 (fr) Procédés et dispositif de test d'analyte pour calculer une thérapie par insuline basale
WO2014209630A3 (fr) Systèmes, dispositifs et/ou procédés d'identification de périodes temporelles de tests glycémiques insuffisants
MX2015003642A (es) Cmpf como biomarcador para diabetes y metodos asociados.
WO2014080267A3 (fr) Procédé et appareil pour la détection de l'insulino-résistance, du diabète et d'une maladie cardiovasculaire
Patton et al. Average daily risk range as a measure for clinical research and routine care
IN2014MN01796A (fr)
WO2014072823A3 (fr) Dispositif de détermination de niveau de glycémie
WO2014049438A3 (fr) Procédé de détermination non invasive de la concentration de glucose sanguin et dispositif pour sa mise en œuvre
Wang An improved integration sensor of non-invasive blood glucose
RU2016102319A (ru) Прибор для измерения аналита и методика настройки конфигурации эксплуатационного диапазона
Moretta et al. AUTONOMIC STRESS REACTIVITY AND CRAVING IN INDIVIDUALS WITH PROBLEMATIC INTERNET USE
ZHU et al. Association of OSAS in patients with type 2 diabetes with levels of tumor necrosis factor-α and plasminogen activator inhibitor
NA et al. Beneficial effects of intensive therapy on arterial intima-media thickness and its risk factors in type 2 diabetic patients
YE et al. The investigation of community type 2 diabetic patients with peripheral arterial disease and nursing countermeasures
Doria et al. Set up of methodological analysis to evaluate antioxidant capacity in serum and saliva using DPPH test method
CHEN et al. Value of FibroScan in noninvasive diagnosis of hepatic steatosis
Xu et al. Realtime calibration of pulse oximetry based on Grey Model
WANG et al. Relationship between HRV and lower extremity arterial disease in aged patients with type 2 diabetes mellitus
ZHANG et al. Design of Calibration Device for Pulse Oximeter Simulator
Moore et al. Continuous glucose monitoring: effects on metabolic control, fear and frequency of hypoglycaemic episodes
ZHOU et al. Study of the correlation between vascular dilation function and insulin resistance as well as serum adiponectin in patients with different rates of glucose metabolism
Schmitt KIT-Thin Film TechnologyProjects
Facchinetti et al. Model of Sensor Error from Multiple Simultaneous Continuous Glucose Monitors in the Same Subject
Yue-Sheng et al. Research progress in applying spectral-domain OCT to explore retinal microstructure changes of diabetic macular edema
SUN et al. Psychometric validation of the Chinese Heartburn Version of Quality of Life in Reflux and Dyspepsia Questionnaire